• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进行性骨化性纤维发育不良的临床与影像学见解:两例报告

Clinical and radiological insights into fibrodysplasia ossificans progressiva: A report on two cases.

作者信息

Rapole Sanika, Mehta Bhavika, Sodhai Vivek

机构信息

Department of Pediatric Orthopaedics, India.

Sancheti Institute for Orthopedics & Rehabilitation, Pune, India.

出版信息

J Clin Orthop Trauma. 2024 Nov 28;60:102846. doi: 10.1016/j.jcot.2024.102846. eCollection 2025 Jan.

DOI:10.1016/j.jcot.2024.102846
PMID:39720346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11663994/
Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic illness marked by progressive heterotopic ossification of tendons, ligaments, fascia, and skeletal muscle, leading to immobility and reduced quality of life. Early recognition is critical to avoiding flare-ups often triggered by trivial trauma or medical interventions. This report presents two early-diagnosed FOP cases-one at 6 months, the other at 18 months-both with typical features and congenital great toe abnormalities. Early detection enables preventive strategies that enhance the quality and longevity of affected children's lives. Increased awareness among healthcare professionals about the unique presentation of FOP is vital for prompt diagnosis.

摘要

进行性骨化性纤维发育不良(FOP)是一种罕见的遗传性疾病,其特征是肌腱、韧带、筋膜和骨骼肌进行性异位骨化,导致活动受限和生活质量下降。早期识别对于避免常由轻微创伤或医疗干预引发的病情发作至关重要。本报告介绍了两例早期诊断的FOP病例——一例6个月大,另一例18个月大——均具有典型特征和先天性大脚趾异常。早期检测有助于采取预防策略,提高患病儿童的生活质量和寿命。提高医疗专业人员对FOP独特表现的认识对于及时诊断至关重要。

相似文献

1
Clinical and radiological insights into fibrodysplasia ossificans progressiva: A report on two cases.进行性骨化性纤维发育不良的临床与影像学见解:两例报告
J Clin Orthop Trauma. 2024 Nov 28;60:102846. doi: 10.1016/j.jcot.2024.102846. eCollection 2025 Jan.
2
Fibrodysplasia Ossificans Progressiva进行性骨化性纤维发育不良
3
Understanding the clinical morbidity and mortality of fibrodysplasia ossificans progressiva: a systematic literature review.进行性骨化性纤维发育不良的临床发病率和死亡率:一项系统文献综述
Orphanet J Rare Dis. 2025 May 31;20(1):262. doi: 10.1186/s13023-025-03763-8.
4
Respiratory oscillometry in individuals with fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良患者的呼吸振荡法
Orphanet J Rare Dis. 2025 Jul 1;20(1):323. doi: 10.1186/s13023-025-03846-6.
5
iMSC-mediated delivery of ACVR2B-Fc fusion protein reduces heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva.iMSC 介导的 ACVR2B-Fc 融合蛋白递送减少纤维发育不良性骨化进展的小鼠模型中的异位骨化。
Stem Cell Res Ther. 2024 Mar 18;15(1):83. doi: 10.1186/s13287-024-03691-7.
6
Early diagnosis of fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良的早期诊断。
Pediatrics. 2008 May;121(5):e1295-300. doi: 10.1542/peds.2007-1980.
7
All Restricted Spines are not Spondyloarthritis: Fibrodysplasia Ossificans Progressiva (FOP) in Monozygotic Twins presenting to Rheumatology Clinic.所有受限脊柱并非都是脊柱关节炎:一对同卵双胞胎中的进行性骨化性纤维发育不良(FOP)病例在风湿病诊所就诊。
Mediterr J Rheumatol. 2025 Jan 8;36(1):128-135. doi: 10.31138/mjr.210524.mta. eCollection 2025 Mar.
8
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial.成纤维细胞性骨化发育不良成人患者flare-ups 的特征及 garetosmab 的影响:LUMINA-1 试验的一项随机、双盲、安慰剂对照的事后分析。
J Bone Miner Res. 2024 Sep 26;39(10):1486-1492. doi: 10.1093/jbmr/zjae140.
9
- and -Related Osteogenesis Imperfecta与……相关的成骨不全症 (你提供的原文不完整,推测这里可能是想表达“某种因素与成骨不全症相关”,但仅从现有的“- and -Related Osteogenesis Imperfecta”很难准确翻译出完整准确的内容,以上是基于可能情况的翻译 )
10
A new BMP type 1 receptor kinase inhibitor for safe and efficient oral treatment to prevent genetically induced heterotopic ossification in mice.一种新型BMP 1型受体激酶抑制剂,用于安全有效的口服治疗,以预防小鼠基因诱导的异位骨化。
Bone. 2025 Oct;199:117565. doi: 10.1016/j.bone.2025.117565. Epub 2025 Jun 18.

本文引用的文献

1
Fibrodysplasia ossificans progressiva: clinical and genetic aspects.进行性骨化性纤维发育不良:临床与遗传方面。
Orphanet J Rare Dis. 2011 Dec 1;6:80. doi: 10.1186/1750-1172-6-80.
2
Early diagnosis of fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良的早期诊断。
Pediatrics. 2008 May;121(5):e1295-300. doi: 10.1542/peds.2007-1980.
3
A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.骨形态发生蛋白I型受体ACVR1中的复发性突变会导致遗传性和散发性进行性骨化性纤维发育不良。
Nat Genet. 2006 May;38(5):525-7. doi: 10.1038/ng1783. Epub 2006 Apr 23.
4
Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良中诊断错误导致的医源性损害。
Pediatrics. 2005 Nov;116(5):e654-61. doi: 10.1542/peds.2005-0469. Epub 2005 Oct 17.
5
Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.环氧化酶同工酶:前列腺素合成与抑制的生物学
Pharmacol Rev. 2004 Sep;56(3):387-437. doi: 10.1124/pr.56.3.3.
6
Catastrophic falls in patients who have fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良患者的灾难性跌倒。
Clin Orthop Relat Res. 1998 Jan(346):110-6.
7
Fibrodysplasia (myositis) ossificans progressiva.进行性骨化性纤维发育不良(骨化性肌炎)
Semin Arthritis Rheum. 1994 Dec;24(3):155-64. doi: 10.1016/0049-0172(94)90071-x.
8
Permanent heterotopic ossification at the injection site after diphtheria-tetanus-pertussis immunizations in children who have fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良患儿在接种白喉-破伤风-百日咳疫苗后注射部位出现永久性异位骨化。
J Pediatr. 1995 May;126(5 Pt 1):762-4. doi: 10.1016/s0022-3476(95)70408-6.
9
Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients.进行性骨化性纤维发育不良。34例患者的临床特征及自然病史。
J Bone Joint Surg Br. 1982;64(1):76-83. doi: 10.1302/0301-620X.64B1.7068725.